Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026)
Tectonic Therapeutic (TECX) reported Non Operating Income of $2.1 million for Q1 2026, down 13.88% year-over-year from $2.4 million in Q1 2025, and up 865.8% quarter-over-quarter from -$269000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Non Operating Income data on file, last reported at $2.1 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $2.1 million, down 13.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (up 20.5% YoY), and the FY2025 annual result was -$380000.0, down 151.28% from the prior year.
- Non Operating Income rose to $2.1 million in Q1 2026 per TECX's latest filing, from -$269000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $3.3 million in Q2 2025 and troughed at -$2.3 million in Q1 2024.
- A 5-year average of $426705.9 and a median of $16000.0 in 2022 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 192100.0% in 2024 and fell as far as 15525.0% in 2024.
- A 5-year view of Non Operating Income shows it stood at $223000.0 in 2022, then soared by 82.06% to $406000.0 in 2023, then surged by 184.98% to $1.2 million in 2024, then tumbled by 123.25% to -$269000.0 in 2025, then soared by 865.8% to $2.1 million in 2026.
- Business Quant data shows TECX's Non Operating Income at $2.1 million in Q1 2026, -$269000.0 in Q4 2025, and -$31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | -269,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -2.25 Mn |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -8,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | -280,000.00 |
| Mar 31, 2022 | -415,000.00 |
| Dec 31, 2021 | -265,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -12,000.00 |